secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2023-06-12T23:59:59+00:00
Accession:  0001193125-23-165409
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CalciMedica receives Nasdaq approval, relisting starts June 14, 2023 under CALC
-------------------------------------------------------------------------------

- Nasdaq approved relisting on Capital Market; trading begins June 14, 2023.
- Common stock to trade under ticker 'CALC' on Nasdaq after OTCQB trading.
- CEO cites improved liquidity, broader investor access, and support for clinical strategy.
- Company continues Phase 2 trials of Auxora for inflammatory diseases.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523165409/0001193125-23-165409-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523165409/d506112d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-165409

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer